돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 42255생성일: 2026년 10월 23일

3-Methylbenzoic acid → N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-3-methylbenzamide

https://huagongshe.com/ko/reaction/42255

반응식

참여 물질

역할이름HCID투입량
반응물3-Methylbenzoic acidHCID 7418—
반응물DiisopropylethylamineHCID 81531—
반응물Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
반응물6-(1H-indol-4-yl)-1H-indazol-4-amineHCID 58268019—
용매DimethylformamideHCID 6228—
생성물N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-3-methylbenzamideHCID 44540402—

반응 단계

3-Methylbenzoic acid (60 mg, 0.44 mmol) was treated with HATU (168 mg, 0.44 mmol) in DMF (0.750 mL) and DIPEA (0.15 mL, 0.86 mmol). The mixture was shaken for five minutes prior to treatment with 6-(1H-indol-4-yl)-1H-indazol-4-amine (50 mg, 0.2 mmol) in DMF (0.350 mL) and was then left to stand at room temperature for 16 hrs. Solvent was removed in vacuo and the product re-dissolved in chloroform (0.3 mL) prior to application on to a pre-conditioned (methanol then chloroform) NH2 cartridge (1 g). Product was eluted after 2 hr with ethyl acetate/methanol (1:1, 3.2 mL), and concentrated under a stream of nitrogen using blow down apparatus. Purification by MDAP (Method C) afforded the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536169B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-0f9fc47f8c304901be6b41edb9604a18
출처 메모uspto-grants-2013_09